Semaglutide slowed stomach emptying in the first hour after a meal, 2017 report found

Semaglutide slowed the rate at which the stomach empties during the first hour after a meal in people with obesity, while leaving overall stomach emptying about the same, according to a 2017 report by Hjerpsted and colleagues. The researchers measured an acetaminophen AUC ratio of 0.73 compared with placebo in that first hour ^[1]. The finding, dated October 2017, still underpins how the prescribing information for semaglutide describes the drug's effect on the stomach ^[1].

How the effect was measured

The work used acetaminophen as a marker of how fast the stomach empties. Acetaminophen is absorbed in the small intestine rather than the stomach, so how much of it reaches the bloodstream in the first hour after a dose offers a signal of how quickly the stomach has moved it along. In this case, acetaminophen exposure in the first hour was lower on semaglutide than on placebo, at a ratio of 0.73, meaning exposure to the marker drug in that window was about 27 percent lower with semaglutide ^[1].

By the end of the measurement period, the two groups looked similar on overall emptying ^[1]. That means the difference was concentrated in the early part of the digestive cycle rather than being a slowdown that lasted throughout.

Semaglutide is the molecule in Ozempic, Wegovy and Rybelsus. The report covers people with obesity. The doses used, the number of participants, how the drug was given, and whether any participants had type 2 diabetes have not been disclosed ^[1].

Why it matters for patients

Slowed stomach emptying is one of the reasons GLP-1 medications are thought to help people feel full sooner and stay full longer, and it appears in the labeling for semaglutide products. This report is the measurement that description rests on ^[1]. The practical detail is the timing: the difference showed up in the first hour after eating, not across the whole digestive cycle.

Several questions patients might ask are not answered by this finding. Whether the first-hour delay explains side effects such as nausea or vomiting has not been reported. Whether it changes how quickly other oral medicines taken around the same time are absorbed has not been reported either.

The participants had obesity. Whether the same pattern appears in people with type 2 diabetes, in people taking semaglutide for weight loss rather than blood sugar, or in people who already have slow stomach emptying has not been reported.

What the finding does establish is that semaglutide's effect on the stomach was measurable and specific enough to be described in the label: a short delay early in digestion, with overall emptying close to normal by the end of the test ^[1]. For anyone reading a package insert or a pharmacy leaflet that mentions gastric emptying, this is the study behind that language, and the size of the effect it describes is modest and time-limited rather than a blanket slowdown of digestion.